Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 ...

Researchers have identified that vericiguat, a new drug for heart failure, is safe in patients with coronary artery disease.

A recent study has found that women with hypertension who take beta-blockers may face a higher risk of heart failure than men ...

The former president was discharged Tuesday morning after being admitted to a hospital on Monday after developing a fever.

The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...

THE TCW trial has demonstrated that fractional flow reserve (FFR)-guided percutaneous PCI plus TAVI is superior to SAVR plus ...

A new study published in the Journal of the American College of Cardiology illuminate the critical relationship between ...

HARRISBURG, Pa. (WHP) — Heart disease is the leading cause of death in the United States, but here's the key: it's ...

Despite advances in prevention and optimal medical therapy, coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide.

Heart artery blockages, also called coronary artery disease, happen when the main blood vessels that supply oxygen and ...